Chromosomal microarray analysis in prenatal diagnosis: ethical considerations of the Belgian approach

Journal of Medical Ethics 46 (2):104-109 (2020)
  Copy   BIBTEX

Abstract

Detection of genetic aberrations in prenatal samples, obtained through amniocentesis or chorion villus biopsy, is increasingly performed using chromosomal microarray (CMA), a technique that can uncover both aneuploidies and copy number variants throughout the genome. Despite the obvious benefits of CMA, the decision on implementing the technology is complicated by ethical issues concerning variant interpretation and reporting. In Belgium, uniform guidelines were composed and a shared database for prenatal CMA findings was established. This Belgian approach sparks discussion: it is evidence-based, prevents inconsistencies and avoids parental anxiety, but can be considered paternalistic. Here, we reflect on the cultural and moral bases of the Belgian reporting system of prenatally detected variants.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,551

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Currents in Contemporary Bioethics.Amy L. McGuire, Melody J. Wang & Frank J. Probst - 2012 - Journal of Law, Medicine and Ethics 40 (4):1040-1046.

Analytics

Added to PP
2019-09-18

Downloads
22 (#977,147)

6 months
12 (#304,424)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references